Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	53.65	328.29	213.66
Graham Fair Price	-17.11	1.15	1.39
PEG	213.56	-3.02	0.96
Price/Book	-14.77	6.12	7.18
Price/Cash Flow	75.14	-1100.71	628.48
Prices/Earnings	78.27	128.89	72.30
Price/Sales	38.62	22.89	16.51
Price/FCF	75.14	-1100.71	628.48
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.04	0.20	0.19
Operating Margin	-17.08	0.04	0.05
ROA	-45.07	< 0.005	0.01
ROE	0.02	0.01	-52.19
ROIC	0.02	< 0.005	-41.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.19	1.07	-82.11
Dividends QOQ	-0.35	0.59	70.87
EBIT QOQ	0.48	-0.36	-23.78
EPS QOQ	0.75	-0.43	-43.15
FCF QOQ	-0.45	-1.61	-257.64
Revenue QOQ	0.42	-0.23	-45.27
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	82.88	113.11	36.46
Days Sales Outstanding (DSO)	130.08	151.52	16.49
Inventory Turnover	1.09	0.80	-26.72
Debt/Capitalization	0.21	0.15	-29.97
Quick Ratio	1.06	1.42	33.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.86	2.23	19.88
Cash	0.34	0.71	108.79
Capex	< 0.005	-0.02	-90.65
Free Cash Flow	0.02	-0.01	-41.66
Revenue	0.81	0.60	-26.30
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.50	1.93	28.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.77	-5.11	6.98
Naive Interpretation	Member

06 - Financial Health · Weak

Rating